Multidisciplinary Approach to Patients With Metastatic Spinal Cord Compression: A Diagnostic Therapeutic Algorithm to Improve the Neurological Outcome.
diagnostic-therapeutic algorithm
neurological deficits
pathological spine fractures
spinal cord compression
spinal metastasis
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
23
03
2022
accepted:
16
05
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
25
6
2022
Statut:
epublish
Résumé
The morbidity associated with metastatic spinal disease is significant because of spinal cord and/or nerve root compression. The purpose of this paper is to define a diagnostic-therapeutic path for patients with vertebral metastases and from this path to build an algorithm to reduce the devastating consequences of spinal cord compression. The algorithm is born from the experience of a primary care center. A spine surgeon, an emergency room (ER) physician, a neuroradiologist, a radiation oncologist, and an oncologist form the multidisciplinary team. The ER physician or the oncologist intercept the patient with symptoms and signs of a metastatic spinal cord compression. Once the suspicion is confirmed, the following steps of the flow-chart must be triggered. The spine surgeon takes charge of the patient and, on the base of the anamnestic data and neurological examination, defines the appropriate timing for magnetic resonance imaging (MRI) in collaboration with the neuroradiologist. From the MRI outcome, the spine surgeon and the radiation oncologist consult each other to define further therapeutic alternatives. If indicated, surgical treatment should precede radiation therapy. The oncologist gets involved after surgery for systemic therapy. In 2021, the Spine and Spinal Cord Surgery department evaluated 257 patients with vertebral metastasis. Fifty-three patients presented with actual or incipient spinal cord compression. Among these, 27 were admitted due to rapid progression of symptoms, neurological deficits and/or spine instability signs. The level was thoracic in 21 cases, lumbar in 4 cases, cervical in 1 case, sacral in 1 case. Fifteen were operated on, 10 of these programmed and 5 in emergency. Patients with a history of malignancy can present to the ER or to the oncology department with symptoms that must be correctly framed in the context of a metastatic involvement. Even when there is no previous cancer history, the patient's pain characteristics and clinical signs must be interpreted to yield the correct diagnosis of vertebral metastasis with incipient or current spinal cord compression. The awareness of the alert symptoms and the application of an integrated paradigm consent to frame the patients with spinal cord compression, obtaining the benefits of a homogeneous step-by-step diagnostic and therapeutic path. Early surgical or radiation therapy treatment gives the best hope for preventing the worsening, or even improving, the deficits. Metastatic spinal cord compression can cause neurological deficits compromising quality of life. Treatment strategies should be planned comprehensively. A multidisciplinary approach and the application of the proposed algorithm is of paramount importance to optimize the outcomes of these patients.
Identifiants
pubmed: 35747823
doi: 10.3389/fonc.2022.902928
pmc: PMC9210572
doi:
Types de publication
Journal Article
Langues
eng
Pagination
902928Informations de copyright
Copyright © 2022 Rispoli, Reverberi, Targato, D’Agostini, Fasola, Trovò, Calci, Fanin and Cappelletto.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
BMJ. 2008 Nov 27;337:a2538
pubmed: 19039017
Eur Spine J. 2016 Dec;25(12):3932-3941
pubmed: 26972427
Eur J Cancer. 2010 Oct;46(15):2696-707
pubmed: 20627705
Rep Pract Oncol Radiother. 2015 Nov-Dec;20(6):454-63
pubmed: 26696786
Spine J. 2019 Sep;19(9):1540-1547
pubmed: 31005624
Int J Oncol. 2011 Jan;38(1):5-12
pubmed: 21109920
J Clin Oncol. 2019 Jan 1;37(1):61-71
pubmed: 30395488
Eur J Radiol. 2009 Mar;69(3):567-73
pubmed: 18191356
J Clin Oncol. 2011 Aug 1;29(22):3072-7
pubmed: 21709187
Chir Organi Mov. 1998 Jan-Jun;83(1-2):167-76
pubmed: 9718825
Oncologist. 2013 Jun;18(6):744-51
pubmed: 23709750
Spine (Phila Pa 1976). 2010 Oct 15;35(22):E1221-9
pubmed: 20562730
J Magn Reson Imaging. 2006 Dec;24(6):1207-20
pubmed: 17075841
Ann Rheum Dis. 2014 Jun;73(6):968-74
pubmed: 24665116
Eur J Cancer. 1994;30A(3):396-8
pubmed: 8204366
Lancet Oncol. 2017 Dec;18(12):e720-e730
pubmed: 29208438
QJM. 2014 Apr;107(4):277-82
pubmed: 24336849
J Clin Oncol. 1998 Apr;16(4):1613-24
pubmed: 9552073
Rofo. 2017 May;189(5):413-422
pubmed: 28449168
J Neurosurg Spine. 2015 May;22(5):518-25
pubmed: 25723122
Spine (Phila Pa 1976). 2015 Dec;40(24):1882-9
pubmed: 26655804
Anticancer Res. 2018 Sep;38(9):4987-4997
pubmed: 30194142
Spine (Phila Pa 1976). 2009 Oct 15;34(22 Suppl):S93-100
pubmed: 19829281
J Neurosurg Spine. 2004 Oct;1(3):287-98
pubmed: 15478367
Lancet. 2005 Aug 20-26;366(9486):643-8
pubmed: 16112300
Orthop Traumatol Surg Res. 2022 Jun;108(4):103274
pubmed: 35331924
Spine (Phila Pa 1976). 2016 Jan;41(1):E50-4
pubmed: 26335676
Orthop Surg. 2019 Dec;11(6):1048-1053
pubmed: 31755205
Oncol Lett. 2020 Apr;19(4):3137-3144
pubmed: 32218864
Neurosurg Clin N Am. 2004 Oct;15(4):365-73
pubmed: 15450871
Paraplegia. 1969 Nov;7(3):179-92
pubmed: 5360915
Front Oncol. 2022 Apr 04;12:884928
pubmed: 35444954
Br J Cancer. 2009 Jun 16;100(12):1867-72
pubmed: 19471276
Spine (Phila Pa 1976). 2017 Jan 1;42(1):E1-E7
pubmed: 27196026
J Natl Compr Canc Netw. 2005 Sep;3(5):711-9
pubmed: 16194459
Can J Neurol Sci. 2011 May;38(3):396-403
pubmed: 21515496
Clin Oncol (R Coll Radiol). 2002 Dec;14(6):472-80
pubmed: 12512970
Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6243s-6249s
pubmed: 17062708
Am J Med. 1988 Mar;84(3 Pt 1):555-8
pubmed: 3279772
Muscle Nerve. 1990;13 Suppl:S16-20
pubmed: 2233877
Continuum (Minneap Minn). 2012 Apr;18(2):312-27
pubmed: 22810129
J Clin Oncol. 2016 Sep 1;34(25):3054-61
pubmed: 27400936
BMJ. 2016 May 19;353:i2539
pubmed: 27199232
CA Cancer J Clin. 2017 Jan;67(1):7-30
pubmed: 28055103
Spine (Phila Pa 1976). 1990 Jan;15(1):1-4
pubmed: 2326692
Cancer. 2005 Jan 15;103(2):320-8
pubmed: 15593360
Ann Oncol. 2016 Nov;27(11):2004-2016
pubmed: 27502726
Lancet Oncol. 2005 Jan;6(1):15-24
pubmed: 15629272
Support Care Cancer. 2019 Aug;27(8):3159-3170
pubmed: 31093768
Eur Spine J. 2020 Dec;29(12):3170-3178
pubmed: 32948899